ResMedRMD

NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices

Devices and cloud software for sleep apnea and respiratory diseases.

Medtech & devices: Medical equipment and devices — from surgery and cardiology to robotics.

Key metrics

Market cap

$29.8B

Price

$205.37

Today

−1.5%

Return YTD

−13.5%

Return 1Y

−18.6%

P/E

19.6

P/S

5.4

P/B

4.6

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

Sleep & respiratorySleep apneaRespiratory equipmentDigital health

In the value chain

Products & services

CPAP devices & masks
Sleep & respiratory equipment
Digital health software

Competitors

Philips
Fisher & Paykel Healthcare
Compumedics

Risks

GLP-1 impact on sleep apnea
Competition

Same segment: Medtech & devices

Intuitive SurgicalISRG StrykerSYK MedtronicMDT Boston ScientificBSX Edwards LifesciencesEW Becton DickinsonBDX GE HealthCareGEHC Zimmer BiometZBH

See where ResMed sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →